An open-label, 2-period, fixed-sequence DDI study of MK-8705 in healthy postmenopausal or oopherectomized females assessing the pharmacokinetics of the combined oral contraceptive levonorgestrel/ethinyl estradiol
Latest Information Update: 02 Sep 2021
At a glance
- Drugs Ulonivirine (Primary) ; Ethinylestradiol/levonorgestrel
- Indications HIV-1 infections
- Focus Pharmacokinetics
Most Recent Events
- 02 Sep 2021 New trial record
- 21 Jul 2021 Results presented at the 11th International AIDS Society Conference on HIV Science